Traduction de «sono bearing receiver system » (Anglais → Français) :

sono bearing receiver system [ Sonobuoy Receiver System | sonobuoy receiver ]

In particular in the area of sickness, such procedures should take account of the position of Member States which bear the costs of allowing insured persons access to their healthcare system and the position of Member States whose institutions bear the cost of benefits in kind received by their insured persons in a Member State other than that in which they are resident.

3. Stresses that benefits that CA may receive in terms of trade preferences are considerable, bearing in mind that replacing the GSP+ with an Association Agreement will bring with it a system of bilateral commitments that are not subject to a time limit and that are such that they will promote investment, the gradual liberalisation of trade in goods and services and public procurement between the parties;

26. In addressing the current humanitarian crisis in northern Africa, notes that Frontex cannot be the main tool to deal with the resulting migration flows originating in the region, and calls on the EU to devise a prompt and coordinated response as part of a coherent, long-term strategy to deal with political transitions and fragile States, thus addressing the root causes of migration flows; urges the Council to put in place a burden-sharing action plan to help resettle refugees from the region, based on the solidarity clause set out in Article 80 of the TFEU, and to provide support for displaced persons in accordance with the provisions laid down in Council Directive 2001/55/EC of 20 July 2001 on minimum standards for giving temporary pr ...[+++]otection in the event of a mass influx of displaced persons, and on measures promoting a balance of efforts between Member States in receiving such persons and bearing the consequences thereof; ; calls on the Council urgently to move forward with the adoption of a Common EU Asylum System and to complete the codecision procedures relating to the establishment of a Joint EU Resettlement Programme and the European Refugee Fund for the period 2008-2013, as recommended by Parliament in May 2010; recalls that Member States are required to observe the principle of non-refoulement;

(Return tabled) Question No. 456 Ms. Kirsty Duncan: With respect to the current pandemic of new influenza A (H1N1): (a) what specific healthcare professional stakeholder groups have been consulted since the beginning of the H1N1 pandemic, what was the consultation process, and what concerns were raised; (b) what concerns from the consultation process have been addressed, what concerns are remaining, and by what date will they be addressed; (c) what, if any, additional funding was requested to address identified challenges; (d) do identified stakeholder groups report there are sufficient human resources and supplies to meet the need during a second wave of H ...[+++]1N1 and, if not, what are the identified gaps; (e) what, if any, additional education and training was requested by stakeholder groups; (f) what procedures are in place to ensure applicability, consistency and clarity of protocols to healthcare professional organizations, and do stakeholders report that they are receiving clear, concise, timely messaging; (g) what, if any, differences exist in how healthcare professionals will be protected among provinces and territories; (h) what specific agreements have been made in respect to assuring sufficient human resources during a second wave; (i) what, if any, differences exist between the national guidelines and those of the provinces and territories, with respect to antivirals, N-95 masks, vaccines, and other personal protective measures, and how should healthcare professionals address any discrepancies; (j) what are the known and suspected benefits and risks of the H1N1 vaccine; (k) what non-clinical and clinical trials have been or are being undertaken regarding the H1N1 vaccine, on what dates were they completed, and what are the outcomes of these trials; (l) what possible side effects, including rare events, might be expected with the H1N1 vaccine; (m) what are the possible legal risks associated with an H1N1 vaccination programme, and what efforts have ...